Re Protocol reUSD: Price, News & Analysis

reUSD is a stablecoin from Re Protocol, a platform that tokenizes reinsurance real-world assets and brings their returns on-chain. Rather than a simple fiat wrapper, reUSD is designed as a yield-bearing dollar backed by a portfolio of reinsurance investments. It trades around $1.09, above par, because its value reflects accrued yield from insurance premiums and capital deployed in the reinsurance market. reUSD represents a growing category of RWA-backed stablecoins that pass real-world investment income to token holders.

Capital backing reUSD is deployed into reinsurance strategies, where returns come from premiums earned for absorbing insurance risk. As those returns accrue, the token's value rises relative to a dollar, so holders benefit without receiving separate distributions. The stablecoin relies on the underlying reinsurance portfolio's performance, custody arrangements and on-chain accounting to track net asset value. Access and redemption typically involve protocol-specific mechanisms and, in many RWA products, KYC or eligibility requirements tied to the tokenized collateral.

reUSD's price is anchored near a dollar but drifts upward as reinsurance yield accrues, explaining its $1.09 level. Key drivers are the performance of the underlying reinsurance investments, the frequency and severity of insured claims, prevailing premium rates, and demand for RWA-backed yield stablecoins. Because returns stem from insurance markets rather than crypto trading, its value is relatively insulated from token speculation but sensitive to underwriting outcomes and the reinsurance cycle.

reUSD carries reinsurance-specific risk: large or clustered insured losses could reduce the backing portfolio's value and impair the token. It also faces RWA custody, counterparty, smart-contract and regulatory risks, and transparency into the underlying assets may be limited. Liquidity is smaller than for major stablecoins, and yield is not guaranteed, so redemption depends on the protocol's solvency and the reinsurance book's health.